Could Vaxart's Vaccine Pill Help to End the Pandemic?
If you could immunize yourself against COVID-19 from the comfort of your home by just taking a pill, I'm guessing you'd prefer that approach to getting poked in the arm at a clinic. And that's what makes Vaxart (NASDAQ: VXRT) a compelling company, not to mention a potentially killer stock to own.
Though it has no recurring revenue or products on the market, Vaxart's oral vaccine technology just might open the door to reaching the level of widespread immunity required to extinguish the pandemic. But it has a lot of work to do to realize that potential, and it isn't the right stock for everyone. Let's take a quick look at how Vaxart's project might be a game-changer.
Image source: Getty Images.
Source Fool.com
